Quality & Compliance For Continuous Improvement

Pharmaceutical Quality; GxP Training, Consulting and Auditing Services

Pharmaceutical Remediation and Quality Systems Compliance

Have A Question? Get In Touch

Helping you with regulatory compliance is the core of our expertise. Our global team of pharmaceutical consultants includes former U.S. FDA and UK MHRA inspectors and experts with decades of experience helping companies to develop strategic plans and address enforcement action.

Take advantage of our learning resources to help you fix and future proof your organization.

For more information on our services, contact pharmamail@nsf.org or visit www.nsfpharma.org 

For the latest regulatory updates and resources download our pharma app.




Article: U.S FDA/EMA Regulatory Inspection and Enforcement Trends 

Webinar: Remediation the Right Way 

Video: Remediation Case Study

EDGE Toolkit: Why Do Successful Pharma Companies Have The Edge?

U.S FDA/EMA Regulatory Inspection and Enforcement Trends 

Why not focus on prevention? Lynne Byers and Jenny Yu from Munich Re Group compare regulatory findings from the U.S. FDA and the EMA. They provide insight into emerging trends from both agencies and highlight the important questions managers need to ask to stay in compliance.

Read the Article >>

Remediation the Right Way 

We believe remediation following a tough inspection is an opportunity to emerge stronger and more confident. Find out how by applying our 3Cs approach. 

Watch the Webinar >>

You can also read our article on the 3Cs approach 

Remediation Case Study

GMP remediation projects are rarely just about upgrading SOPs and retraining staff. John Johnson shares how the best firms use remediation projects proactively to alter the mind-set for quality and reduce ongoing costs to the business.

Watch the Video >>

Why Do Successful Pharma Companies Have The Edge?

Our EDGE toolkit can help improve GMP and business performance. Find out how your pharma business is performing across multiple sites and departments by bringing your quality systems into sharp focus.

Our EDGE Toolkit >>

A Beginner’s Guide To Quality Risk Management (QRM)  

The pharmaceutical industry approach to assessing and controlling quality risks has largely been empirical. This is often fine but in more complex or hazardous situations, the pharmaceutical industry could benefit from a number of very helpful tools and techniques. 

> > Discover more

Follow us

Go to article: Home | The path of yeast resistanceGo to article: NSFGo to article: EditorialGo to article: ContentsGo to article: NewsGo to article: Emirates SkyCargoGo to article: The pharma industry briefingGo to article: A resolution for the new decade: resolve the US opioid crisisGo to article: Eurofins CDMOGo to article: Precision medicine: what barriers remain?Go to article: Can recyclable packaging turn the pharma industry green?Go to article: Phoenix Company InsightGo to article: PhoenixGo to article: Vertex’s Trikafta: treating the genetic basis of cystic fibrosis Go to article: Accurate Biometrics Company Insight Go to article: Accurate BiometricsGo to article: Q&A: talking innovation with the Association for the Cannabinoid IndustryGo to article: Yeast of burden: how to develop better antifungal drugsGo to article: Loose lips bring risks: protecting pharma against leaks and fraud Go to article: Why are patients struggling to access life-saving immune globulin?Go to article: MimotopesGo to article: Deals in brief powered by GlobalDataGo to article: Nolato Company Insight Go to article: NolatoGo to article: The key list powered by GlobalDataGo to article: EventsGo to article: Next issue